Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withdrawal of Inhaled Corticosteroids in COPD (WISP)
NCT00440687Phase 4Completed
- Sponsor
- Queen Mary University of London
- Start
- Jan 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Flixotide Continuation with Placebo Withdrawal (2 arms). Primary endpoint: Frequency of exacerbations at 1 year. Started Jan 2001; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00440687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440687.